Clinical Trials Browser

Phase NA × Carcinoma, Non-Small-Cell Lung × Immune Checkpoint Inhibitors × Clear all

NCT05248022 2024-01-09

Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung